Advertisement

Role of Oxalobacter formigenes Colonization in Calcium Oxalate Kidney Stone Disease

  • John Knight
  • Ross P. Holmes

Abstract

Oxalobacter formigenes is part of the bacterial flora in the large intestine of humans and many other mammalian species. It is unique in that it requires oxalate both as an energy and carbon source. A lack of colonization with O. formigenes is a risk factor for idiopathic recurrent calcium oxalate stone disease. Protection against calcium oxalate stone disease appears to be due to the oxalate degradation that occurs in the gut as measurements of 24 h urinary oxalate indicate that O. formigenes colonized calcium oxalate stone formers excrete less oxalate compared to non-colonized individuals when ingesting standardized diets. There is also some evidence that suggests a possible mechanism involving intestinal oxalate secretion triggered by the bacterium itself, as O. formigenes colonization appears to lower plasma oxalate. Whether high oral doses of this organism can promote sufficient intestinal oxalate secretion to diminish the oxalate burden on the kidney in individuals with Primary Hyperoxaluria is currently being tested by OxThera, Inc. in a phase 2 clinical trial. Much still remains to be learned about how O. formigenes establishes and maintains gut colonization and the precise mechanisms by which it modifies stone risk.

Keywords

Calcium Oxalate Urinary Oxalate Calcium Oxalate Stone Primary Hyperoxaluria Urinary Oxalate Excretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The work from our laboratory was supported by NIH grants DK62284 and DK87967.

References

  1. 1.
    Al-Wahsh I, Wu Y, Liebman M. Acute probiotic ingestion reduces gastrointestinal oxalate absorption in healthy subjects. Urol Res. 2012;40(3):191–6. doi: 10.1007/s00240-011-0421-7.CrossRefPubMedGoogle Scholar
  2. 2.
    Allison MJ, Cook HM. Oxalate degradation by microbes of the large bowel of herbivores: the effect of dietary oxalate. Science. 1981;212(4495):675–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Allison MJ, Dawson KA, Mayberry WR, Foss JG. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol. 1985;141(1):1–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Allison MJ, Littledike ET, James LF. Changes in ruminal oxalate degradation rates associated with adaptation to oxalate ingestion. J Anim Sci. 1977;45(5):1173–9.PubMedGoogle Scholar
  5. 5.
    Anantharam V, Allison MJ, Maloney PC. Oxalate: formate exchange. The basis for energy coupling in Oxalobacter. J Biol Chem. 1989;264(13):7244–50.PubMedGoogle Scholar
  6. 6.
    Batislam E, Yilmaz E, Yuvanc E, Kisa O, Kisa U. Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis. Urol Res. 2012;40(5):455–60. doi: 10.1007/s00240-011-0449-8.CrossRefPubMedGoogle Scholar
  7. 7.
    Capitani G, Eidam O, Glockshuber R, Grutter MG. Structural and functional insights into the assembly of type 1 pili from Escherichia coli. Microbes Infect. 2006;8(8):2284–90. doi: 10.1016/j.micinf.2006.03.013.CrossRefPubMedGoogle Scholar
  8. 8.
    Cornelius JG, Peck AB. Colonization of the neonatal rat intestinal tract from environmental exposure to the anaerobic bacterium Oxalobacter formigenes. J Med Microbiol. 2004;53(Pt 3):249–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Cornick NA, Allison MJ. Anabolic Incorporation of Oxalate by Oxalobacter formigenes. Appl Environ Microbiol. 1996;62(8):3011–3.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Cornick NA, Allison MJ. Assimilation of oxalate, acetate, and CO2 by Oxalobacter formigenes. Can J Microbiol. 1996;42(11):1081–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol. 2002;68(8):3841–7.PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Freter R, Brickner H, Fekete J, Vickerman MM, Carey KE. Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun. 1983;39(2):686–703.PubMedCentralPubMedGoogle Scholar
  13. 13.
    Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol. 2007;2(4):745–9. doi: 10.2215/CJN.00600207.CrossRefPubMedGoogle Scholar
  14. 14.
    Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int. 2006;69(4):691–8. doi: 10.1038/sj.ki.5000162.CrossRefPubMedGoogle Scholar
  15. 15.
    Hatch M, Freel RW. A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion. Urolithiasis. 2013;41(5):379–84. doi: 10.1007/s00240-013-0601-8.CrossRefPubMedGoogle Scholar
  16. 16.
    Hatch M, Gjymishka A, Salido EC, Allison MJ, Freel RW. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol. 2011;300(3):G461–9. doi:ajpgi.00434.2010 [pii]  10.1152/ajpgi.00434.2010.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int. 2006;70(7):1305–11. doi: 10.1038/sj.ki.5001707.CrossRefPubMedGoogle Scholar
  18. 18.
    Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res. 2005;33(5):372–5. doi: 10.1007/s00240-005-0497-z.CrossRefPubMedGoogle Scholar
  19. 19.
    Jiang J, Knight J, Easter LH, Neiberg R, Holmes RP, Assimos DG. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol. 2011;186(1):135–9. doi: 10.1016/j.juro.2011.03.006.PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Kaufman DW, Kelly JP, Curhan GC, Anderson TE, Dretler SP, Preminger GM, Cave DR. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 2008;19(6):1197–203. doi:ASN.2007101058 [pii]  10.1681/ASN.2007101058.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol. 2011;25(4):673–9. doi: 10.1089/end.2010.0462.PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Kharlamb V, Schelker J, Francois F, Jiang J, Holmes RP, Goldfarb DS. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol. 2011;25(11):1781–5. doi: 10.1089/end.2011.0243.PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Knight J, Deora R, Assimos DG, Holmes RP. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis. 2013;41(3):187–96. doi: 10.1007/s00240-013-0566-7.PubMedCentralCrossRefPubMedGoogle Scholar
  24. 24.
    Kuhner CH, Hartman PA, Allison MJ. Generation of a proton motive force by the anaerobic oxalate-degrading bacterium Oxalobacter formigenes. Appl Environ Microbiol. 1996;62:2494–500.PubMedCentralPubMedGoogle Scholar
  25. 25.
    Lange JN, Wood KD, Wong H, Otto R, Mufarrij PW, Knight J, Akpinar H, Holmes RP, Assimos DG. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology. 2012;79(6):1286–9. doi: 10.1016/j.urology.2011.11.017.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int. 2005;68(3):1244–9. doi: 10.1111/j.1523-1755.2005.00520.x.CrossRefPubMedGoogle Scholar
  27. 27.
    Lieske JC, Tremaine WJ, De Simone C, O’Connor HM, Li X, Bergstralh EJ, Goldfarb DS. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int. 2010;78(11):1178–85. doi: 10.1038/ki.2010.310.PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Mittal RD, Kumar R, Bid HK, Mittal B. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol. 2005;19(1):102–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Mogna L, Pane M, Nicola S, Raiteri E. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? J Clin Gastroenterol. 2014;48 Suppl 1:S91–5. doi: 10.1097/MCG.0000000000000228.CrossRefPubMedGoogle Scholar
  30. 30.
    Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet. 1998;352:1026–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Sidhu H, Schmidt ME, CorneliusT JG, Thamiselvam S, Khan SR, Hesse A, Peck AB. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol. 1999;10:S334–40.PubMedGoogle Scholar
  32. 32.
    Sidhu H, Yenatska L, Ogden SD, Allison MJ, Peck AB. Natural colonization of children in the Ukraine with the intestinal bacterium, Oxalobacter formigenes, using a PCR-based detection system. Mol Diagn. 1997;2:89–97.CrossRefPubMedGoogle Scholar
  33. 33.
    Siener R, Bade DJ, Hesse A, Hoppe B. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria. J Transl Med. 2013;11:306. doi: 10.1186/1479-5876-11-306.PubMedCentralCrossRefPubMedGoogle Scholar
  34. 34.
    Siener R, Bangen U, Sidhu H, Honow R, von Unruh G, Hesse A. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int. 2013;83(6):1144–9. doi: 10.1038/ki.2013.104.CrossRefPubMedGoogle Scholar
  35. 35.
    Troxel SA, Sidhu H, Kaul P, Low RK. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol. 2003;17(3):173–6.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Alabama at BirminghamBirminghamUSA

Personalised recommendations